We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety Study of Oral MGCD265 Administered With Interruption to Subjects With Advanced Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00679133
Recruitment Status : Completed
First Posted : May 16, 2008
Last Update Posted : January 8, 2015
Information provided by (Responsible Party):
Mirati Therapeutics Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2011
  Study Completion Date : March 2011